ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,410
Diagnostic referrals
1,028
Outstanding pathways
306

Screening pathway

  1. Screening5,410Encounters
  2. Positive finding1,897Documented findings
  3. Referral1,028Diagnostic referrals
  4. Follow-up1,283Diagnostic visits
  5. Outcome722Resolved pathways

Stage totals use different units. Pending pathways: 306. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0460 · EXP-0460Synthetic · Site D

Full participant history through 2027-06-10, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-12-07
  4. · Diagnostic referral · EXP-0460-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Contact difficulty
  8. · Contact attempt · Unsuccessful
  9. · Contact attempt · Unsuccessful
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Missed
  12. · Diagnostic booking · Rebooking
  13. · Diagnostic visit · Attended
  14. · Diagnosis · Colposcopy · Biopsy collected
  15. · Diagnosis · Histopathology · No high-grade lesion identified
  16. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-09-06
  17. · Follow-up disposition · Resolved · EXP-0460-T-R
  18. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  19. · Surveillance result · HPV DNA · Invalid HPV result · Inadequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0454 · Expanded synthetic participant 0454Site D — Community Engagement Programme
EXP-0455 · Expanded synthetic participant 0455Site A — Urban Referral Hub
EXP-0456 · Expanded synthetic participant 0456Site A — Urban Referral Hub
EXP-0457 · Expanded synthetic participant 0457Site D — Community Engagement Programme
EXP-0458 · Expanded synthetic participant 0458Site D — Community Engagement Programme
EXP-0459 · Expanded synthetic participant 0459Site A — Urban Referral Hub
EXP-0460 · Expanded synthetic participant 0460Site D — Community Engagement Programme
EXP-0461 · Expanded synthetic participant 0461Site A — Urban Referral Hub
EXP-0462 · Expanded synthetic participant 0462Site D — Community Engagement Programme
EXP-0463 · Expanded synthetic participant 0463Site C — Rural Outreach Programme
EXP-0464 · Expanded synthetic participant 0464Site D — Community Engagement Programme
EXP-0465 · Expanded synthetic participant 0465Site C — Rural Outreach Programme
EXP-0466 · Expanded synthetic participant 0466Site A — Urban Referral Hub
EXP-0467 · Expanded synthetic participant 0467Site E — Resource-Constrained Navigation Programme
EXP-0468 · Expanded synthetic participant 0468Site C — Rural Outreach Programme
EXP-0469 · Expanded synthetic participant 0469Site D — Community Engagement Programme
EXP-0470 · Expanded synthetic participant 0470Site C — Rural Outreach Programme
EXP-0471 · Expanded synthetic participant 0471Site D — Community Engagement Programme
EXP-0472 · Expanded synthetic participant 0472Site A — Urban Referral Hub
EXP-0473 · Expanded synthetic participant 0473Site E — Resource-Constrained Navigation Programme
EXP-0474 · Expanded synthetic participant 0474Site E — Resource-Constrained Navigation Programme
EXP-0475 · Expanded synthetic participant 0475Site A — Urban Referral Hub
EXP-0476 · Expanded synthetic participant 0476Site D — Community Engagement Programme
EXP-0478 · Expanded synthetic participant 0478Site D — Community Engagement Programme
EXP-0480 · Expanded synthetic participant 0480Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1968
HPV DNA
2715
Cytology
727

Navigation activity

Barrier documented
930
Contact attempt
1497
Navigation intervention
417
Diagnostic booking
1298
Diagnostic visit
1283

Documented barriers

Contact difficulty
297
Transport difficulty
308
Appointment coordination
325

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.